About
GNI is a Japanese subsidiary of the US corporation Gene Networks, Inc.(2008 liquidation) and started with basic research on gene analysis by a small team of young scientists. Later, it was listed on the Tokyo Stock Exchange Mothers in 2007 and launched in 2014 as a full-fledged pharmaceutical company by launching a new drug. The Group has business bases in China and Japan, two of the world's largest economies, and has its own pharmaceutical factory in China, thereby conducting integrated business activities from new drug discovery and clinical development to manufacturing and sales. This is extremely rare in the biotech industry.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 2,068 investors are based in Tokyo, Tokyo, Japan.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Tokyo, Japan
Contact Information
linkedin.com/in/••••••••
Find more investors like GNI
Search Investors